BIOMERICA INC(NASDAQ:BMRA) stock News

BMRA Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Biomerica, Inc.

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

a month ago - By: Biomerica, Inc.

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer

2 months ago - By: Biomerica, Inc.

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

2 months ago - By: Biomerica, Inc.

Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

3 months ago - By: Biomerica, Inc.

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

3 months ago - By: Biomerica, Inc.

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

4 months ago - By: Biomerica, Inc.

Biomerica Announces Reverse Stock Split

4 months ago - By: Biomerica, Inc.

Biomerica Reports Third Quarter Fiscal 2025 Financial Results

7 months ago - By: Benzinga - Mentions: WHLR ATRA DATS LFLY ...

US Stocks Edge Lower; Retail Sales Increase Less Than Expected

4 months ago - By: Biomerica, Inc.

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection

4 months ago - By: Biomerica, Inc.

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage

4 months ago - By: Benzinga - Mentions: ICAD SYRA SXTC PHIO ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

5 months ago - By: Biomerica, Inc.

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

6 months ago - By: Biomerica, Inc.

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

7 months ago - By: Biomerica, Inc.

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

7 months ago - By: Biomerica, Inc.

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

9 months ago - By: Biomerica, Inc.

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis

9 months ago - By: Biomerica, Inc.

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

9 months ago - By: Biomerica, Inc.

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

10 months ago - By: Biomerica, Inc.

BIOMERICA INC (BMRA) Stock News

BMRA Latest News, Press Relases and Analysis

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

Biomerica Announces Reverse Stock Split

Biomerica Reports Third Quarter Fiscal 2025 Financial Results

US Stocks Edge Lower; Retail Sales Increase Less Than Expected

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage

12 Health Care Stocks Moving In Wednesday's Intraday Session

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Biomerica Reports First Quarter Fiscal 2025 Financial Results